Catalyst Wire Dossier Catalyst Wire Dossier

Biejia-Ruangan Compound

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biejia-Ruangan Compound, covering 2025-04-11 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment [Phase 4]

See pricing